Cyltezo (adalimumab-adbm injection, for subcutaneous use)

Cyltezo (adalimumab-adbm injection) is a tumor necrosis factor (TNF) blocker indicated for treatment of:

Yusimry (adalimumab-aqvh injection)

Yusimry (adalimumab-aqvh) is a tumor necrosis factor (TNF) blocker used for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis; reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older; reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis; reducing signs and symptoms in adult patients with active ankylosing spondylitis; treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older; treatment of moderately to severely active ulcerative colitis in adult patients; and treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.

Amjevita (adalimumab-atto)

Amjevita (adalimumab-atto) injection is a tumor necrosis factor (TNF) blocker indicated for treatment of rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), adult Crohn's disease (CD), ulcerative colitis (UC), and plaque psoriasis (Ps).

Hadlima (adalimumab-bwwd injection)

Hadlima (adalimumab-bwwd) is a tumor necrosis factor (TNF) blocker indicated for treatment of rheumatoid Arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), adult Crohn's disease (CD), ulcerative colitis (UC), and plaque psoriasis (Ps). Hadlima is biosimilar to Humira (adalimumab).

Hulio (adalimumab-fkjp njection)

Hulio (adalimumab-fkjp) is a tumor necrosis factor (TNF) blocker used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, ulcerative colitis, and plaque psoriasis.

Imraldi (adalimumab-xxxx injection, for subcutaneous use)

Imraldi (adalimumab injection, solution) is a tumor necrosis factor (TNF) blocker used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, ulcerative colitis, and plaque psoriasis.

Differin Gel .3% (adapalene)

Differin (adapalene) Gel 0.3% is a topical (applied to the skin) medication similar to vitamin A used to treat severe acne in people who are at least 12 years old. Differin Gel 0.3% is available in generic form.

Epiduo Gel (adapalene and benzoyl peroxide gel)

Epiduo Forte (adapalene and benzoyl peroxide gel 0.3%/2.5%)

Epiduo Forte (adapalene and benzoyl peroxide) Gel is a combination of a synthetic retinoid and an antibacterial and keratolytic agent indicated for the topical treatment of acne vulgaris.

Differin Cream (adapalene cream)

Differin (adapalene) Cream, 0.1% is a retinoid indicated for the topical treatment of acne vulgaris.